2,071 results on '"Gerstein, Hertzel"'
Search Results
2. Improving analysis of cognitive outcomes in cardiovascular trials using different statistical approaches
3. Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial
4. Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes
5. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
6. High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies
7. Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes
8. General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial
9. GDF15 promotes weight loss by enhancing energy expenditure in muscle
10. Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial
11. Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study
12. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study
13. Impact of COVID-19 Lockdown on Occurrence of Acute Complications of Type 1 and Type 2 Diabetes and Overall Glycemic Management
14. Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: A cohort study
15. Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers
16. Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia: Experiences from the outcome reduction with an Initial Glargine Intervention trial
17. The Data Monitoring Committee: A Collective or a Collection?
18. Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study
19. Thyroid Dysfunction and Cardiovascular Events in Patients With Dysglycemia
20. Obesity in late adolescence and incident type 1 diabetes in young adulthood
21. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study
22. World-wide variations in tests of cognition and activities of daily living in participants of six international randomized controlled trials
23. Patient Perspectives on the Ambulatory Glucose Profile Report for Type 1 Diabetes Management in Adults: A National Online Survey
24. The effects of diabetes on gas transfer capacity, lung volumes, muscle strength and cardio- pulmonary responses during exercise
25. Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial
26. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation
27. Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
28. Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation
29. Author Correction: Identification of genetic effects underlying type 2 diabetes in South Asian and European populations
30. A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
31. Identification of genetic effects underlying type 2 diabetes in South Asian and European populations
32. Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial
33. Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐O trial.
34. Cognitive function in adolescence and the risk of early-onset stroke.
35. Development and first‐stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes.
36. Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
37. Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial
38. Consensus report: definition and interpretation of remission in type 2 diabetes
39. Insulin Therapy: The Discovery That Shaped a Century
40. Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study
41. How clinically relevant is statin-induced diabetes?
42. Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants
43. Adolescent cognitive function and incident early-onset type 2 diabetes
44. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
45. Effect of Diabetes Health Coaching on Glycemic Control and Quality of Life in Adults Living With Type 2 Diabetes: A Community-Based, Randomized, Controlled Trial
46. Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial
47. A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity.
48. The association of red and processed meat with gestational diabetes mellitus: Results from 2 Canadian birth cohort studies.
49. Contemporary Clinical Perspectives on Targeting Remission of Type 2 Diabetes.
50. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.